Cimeio Therapeutics
Eva Maria Grossjohann has four years of work experience. From 2022 to present, they have been a Senior Research Associate at Cimeio Therapeutics. From 2018 to 2022, they were a Senior Research Associate and Research Associate at Roche. From 2017 to 2018, they were a Research Assistant at CellGenix GmbH. From 2016 to 2017, they completed a Master Thesis Oncology/ Immunology at Universitätsklinikum Hamburg Eppendorf.
Eva Maria Grossjohann obtained a Master of Science (M.Sc.) in Molecular Life Sciences from the University of Hamburg between 2014 and 2017.
This person is not in any offices
Cimeio Therapeutics
Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases.